-
Forward Look
Does Testicular Cancer Screening Save Lives?Doctors recommend self-exam, even though guidelines discourage it.
by Roxanne Nelson
-
Genomic Testing: The Risk of Knowing Too MuchSophisticated tests can generate a wealth of information about a patient's cancer or disease risk. But they also raise serious questions.
by Alexandra Goho
-
A Dose of PrecisionStereotactic radiation therapy–heavily marketed to consumers–is gaining momentum as a more convenient treatment. But it's not for every patient.
by Sharon Reynolds
-
Healthy Habits
A Cup of Tea?Black tea consumption may be associated with a reduced risk of ovarian cancer.
by Kurt Ullman
-
Q&A
Paying Attention to DepressionPsychiatrist Michael Sharpe suggests a new approach to identifying and treating depression in cancer patients.
by Marci A. Landsmann
-
Forward Look
National Clinical Trials Network Now UnderwayRevamped program aims to get new treatments to patients faster.
by Michael Eisenstein
-
Forward Look
A Champion for PreventionQ&A with Elmer Huerta, the director of the Cancer Preventorium at MedStar Washington Hospital Center
by Sue Rochman
-
Forward Look
Personalizing Prostate Cancer TreatmentActive surveillance may not be right for all African-American men with low-grade prostate cancer.
by Stephen Ornes
-
Lighting a Fire Under Tobacco-Related CancersAs researchers unravel the extent and scientific underpinnings of tobacco-related cancers and addiction, patients can seek support to quit tobacco or cope with the stigma often associated with these cancers.
by Stephen Ornes
-
Telling Cancer’s StoryA Pulitzer Prize-winning book about cancer becomes a documentary after noted filmmaker Ken Burns signs on.
by Marilyn Fenichel
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
